FUSN Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by 0.06% compare to its pairs and should correct downwards.

Stats
Šios dienos apimtis	6.08M
Vidutinė apimtis	2.04M
Rinkos kapitalizacija	1.83B
EPS	$-0.400 ( Q1 \| 2024-05-07 )
Kita pelno data	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-15.39 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00500 (0.02%)

AADI 0.00%

ABCL 0.98%

ABCM 0.04%

ABEO 0.22%

ABIO 2.17%

ABOS -1.20%

ABSI -0.59%

ABUS 0.33%

ABVX -0.22%

ACAD 0.64%

ACER -17.95%

ACET 0.76%

ACGN 1.29%

ACHL -2.44%

ACHV 1.63%

ACIU 0.00%

ACLX 0.28%

ACRV 0.73%

ACST 0.62%

ACXP 1.68%

ADAG -5.64%

ADAP -0.92%

ADGI 0.87%

ADIL -1.57%

ADMA 0.00%

ADPT -1.27%

ADTX -1.27%

ADVM -0.07%

ADXN -6.11%

AEON 11.51%

AEZS -5.44%

AFMD -0.59%

AGEN -4.31%

AGIO 0.56%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 53.45%

AKBA -0.95%

AKRO 0.15%

AKTX -2.70%

AKUS 0.00%

ALBO 0.00%

ALDX 1.35%

ALEC -0.55%

ALGS -0.25%

ALKS 0.44%

ALLK -0.85%

ALLO -1.34%

ALLR -2.33%

ALNA 3.16%

ALNY -0.32%

ALPN 0.00%

ALPX 0.00%

ALRN -0.31%

ALT -1.35%

ALVR 2.25%

ALXN 0.00%

ALXO -1.49%

ALZN 0.00%

AMRN -0.52%

AMTI -3.13%

ANAB -0.94%

ANEB -5.58%

ANGN 0.00%

ANIX -1.15%

ANL 0.61%

ANNX -0.19%

ANPC -3.15%

APGE 0.36%

APGN 8.48%

APGNW 30.65%

APLM 8.82%

APLS -0.55%

APLT 0.21%

APM 1.33%

APOP 0.38%

APRE 2.44%

APTO 0.68%

APTX 3.17%

APVO -0.02%

ARAV -13.39%

ARCT -0.76%

ARDS 20.48%

ARDX -0.45%

ARGX 0.48%

ARNA 0.00%

ARPO -0.90%

ARQT -1.01%

ARTL -4.55%

ARTLW 9.80%

ARVN 0.00%

ARWR -0.44%

ASLN 2.75%

ASMB -0.86%

ASND 0.02%

ATAI 0.37%

ATHA -1.15%

ATHE -1.61%

ATHX -33.50%

ATNF -4.37%

ATOS 0.87%

ATRA -2.10%

ATXI -1.66%

ATXS 0.45%

AUPH -0.54%

AURA 0.68%

AUTL -0.70%

AVBP -0.27%

AVEO 0.00%

AVIR -0.42%

AVRO -0.31%

AVTE -2.42%

AVTX 4.15%

AVXL 0.27%

AXLA 0.00%

AXSM 0.07%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.07%

BCAB 1.92%

BCDA -0.30%

BCDAW -33.33%

BCEL -1.32%

BCLI -0.73%

BCRX -1.84%

BCTX -0.68%

BCTXW 0.00%

BCYC 1.49%

BDRX 0.06%

BDTX -0.55%

BEAM -0.12%

BFRA -2.91%

BGNE -1.47%

BIOR 0.03%

BIVI 1.73%

BLCM -6.68%

BLI -5.88%

BLPH -0.79%

BLRX 2.36%

BLTE -0.72%

BLU 0.03%

BLUE -0.63%

BMEA -0.20%

BMRN 0.44%

BNOX -3.57%

BNTC 2.46%

BNTX -0.50%

BOLD 0.49%

BOLT -0.50%

BPMC 0.89%

BPTH 1.26%

BPTS -13.47%

BRNS 2.96%

BRTX -9.83%

BTAI -1.47%

BTTX -7.50%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 0.00%

CABA -3.39%

CADL -0.97%

CALA 60.00%

CALC -1.62%

CALT -0.64%

CAPR -1.21%

CARA 8.02%

CARM 0.97%

CASI -2.41%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 2.61%

CCCC -2.88%

CCXI 0.00%

CDAK 0.00%

CDIO -3.01%

CDIOW 0.00%

CDMO -0.93%

CDMOP 0.04%

CDT -6.11%

CDTTW 294.32%

CDTX -0.08%

CDXC -1.18%

CDXS -1.51%

CELC 0.62%

CELU 7.05%

CELUW -9.52%

CERC -1.68%

CERE 0.19%

CERO -4.29%

CEROW -44.78%

CFRX -27.95%

CGEM -2.21%

CGEN -1.02%

CGON 1.30%

CGTX 1.37%

CHMA -6.00%

CHRS 0.00%

CINC 0.00%

CING 4.48%

CINGW -48.24%

CKPT -0.49%

CLBS -16.75%

CLDX 0.57%

CLGN 0.30%

CLLS -6.54%

CLNN 0.37%

CLNNW -41.25%

CLRB 0.74%

CLSD 0.86%

CLSN -0.68%

CLVS 0.00%

CMMB 10.18%

CMND 3.65%

CMPI 0.00%

CMPX 1.71%

CMRA 0.40%

CMRAW 33.33%

CMRX -0.01%

CNCE 0.00%

CNSP -5.17%

CNST 0.00%

CNTA 0.31%

CNTB 3.13%

CNTX -1.03%

COCP 0.42%

COEPW -0.66%

COGT -0.11%

CORT -0.28%

COYA 2.22%

CPRX -0.33%

CRBP -2.67%

CRBU -0.57%

CRDF -0.75%

CRGX 0.00%

CRIS 0.73%

CRNX -0.89%

CRSP 0.09%

CRTX 2.63%

CRVO 1.93%

CRVS 0.00%

CSBR 1.19%

CTCX -8.04%

CTIC 0.06%

CTMX 1.82%

CTNM -2.94%

CTXR 1.43%

CUE -0.75%

CVAC -2.30%

CVKD -0.12%

CWBR -2.55%

CYAD -12.96%

CYCC -2.45%

CYCCP -1.79%

CYCN 6.00%

CYT -2.27%

CYTK -0.93%

CYTO -3.23%

DARE 1.19%

DAWN 0.54%

DBTX -0.81%

DBVT 1.01%

DFFN 10.28%

DICE 0.06%

DMAC -0.42%

DNLI 0.10%

DNTH 0.04%

DOMH 1.99%

DRMA 0.00%

DRMAW 0.00%

DRNA 0.00%

DRTS -1.32%

DRTSW 1.01%

DRUG 0.00%

DSGN 0.26%

DTIL -1.19%

DYAI -5.29%

EARS -1.77%

EDIT 2.46%

EDSA 1.04%

EFTR -3.13%

EFTRW -0.26%

EIGR 0.00%

ELAB -2.87%

ELDN 0.71%

ELEV -0.84%

ELOX -12.50%

ELTX -2.33%

ELVN -0.65%

ELYM 0.52%

ENGN -3.89%

ENGNW -5.29%

ENLV 0.73%

ENOB 1.79%

ENSC 0.88%

ENTA -0.75%

ENTO 0.48%

ENTX 1.45%

ENVB 1.56%

EPIX 0.00%

EPRX -0.19%

EPZM 0.00%

EQ 1.40%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.99%

ERNA 4.79%

ERYP 1.30%

ESLA 1.14%

ESLAW -9.25%

ETNB -0.45%

ETON 1.19%

ETTX 0.00%

EVAX 4.45%

EVGN -2.55%

EVLO 50.00%

EWTX -0.58%

EXAI 0.00%

EXEL 0.00%

EYEG -0.43%

EYEN -0.33%

EYPT -0.84%

FATE -0.84%

FBIO 1.04%

FBIOP 1.09%

FBLG 0.30%

FBRX -7.46%

FDMT -0.67%

FENC 0.74%

FGEN 0.88%

FHTX 9.52%

FIXX 0.77%

FMTX 0.00%

FNCH -6.25%

FOLD -0.50%

FREQ 4.76%

FRLN 0.15%

FRTX -0.54%

FSTX 0.00%

FTRE 0.58%

FULC -1.43%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.20%

GANX -0.38%

GBIO 1.37%

GBT 0.01%

GDTC -7.21%

GERN -2.03%

GHRS 3.42%

GLMD -3.30%

GLPG 0.80%

GLSI -2.51%

GLTO 0.00%

GLUE 0.00%

GLYC 1.92%

GMAB 0.85%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT 0.97%

GNLX 0.00%

GNPX 1.84%

GNTA 0.00%

GOSS 10.46%

GOVX 18.75%

GOVXW -24.72%

GPCR 0.42%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -1.42%

GRTX -4.26%

GTHX 0.38%

GUTS 0.28%

GXGXW 41.67%

GYRE 0.17%

HALO -0.01%

HARP 0.09%

HCWB -9.73%

HEPA -6.36%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 0.56%

HOTH -3.73%

HOWL -1.27%

HRMY 0.00%

HRTX 2.64%

HSTO 62.16%

HUMA 0.81%

HUMAW -5.97%

IBRX 1.72%

ICCC 2.84%

ICPT 0.21%

ICU -0.50%

ICUCW -10.39%

ICVX -0.91%

IDRA -23.04%

IDYA -0.13%

IFRX -3.21%

IGMS 0.14%

IKNA 1.15%

IKT 8.90%

IMAB -2.58%

IMCR -1.43%

IMGN 0.02%

IMGO 0.00%

IMMP -0.37%

IMMX -0.49%

IMNM -0.46%

IMNN -0.90%

IMPL -27.27%

IMRA 15.96%

IMRN -2.78%

IMRX 0.32%

IMTX -0.38%

IMTXW -2.70%

IMUX 1.75%

IMV 0.00%

IMVT -0.28%

INAB -1.96%

INBX -0.35%

INCY 0.52%

INDP -3.03%

INFI -52.38%

INKT -0.39%

INM 4.92%

INMB -0.60%

INO -0.67%

INSM -0.61%

INTS 0.84%

INVA 1.48%

INZY 0.43%

IOBT -0.81%

IONS -0.37%

IOVA -0.49%

IPA 0.00%

IPHA -10.64%

IPSC 0.00%

IRON -1.03%

ISEE 0.38%

ITOS -0.84%

ITRM -2.61%

IVA 2.64%

IVVD 0.00%

JAGX 1.85%

JANX -0.15%

JAZZ 0.06%

JNCE 0.00%

JSPR -0.90%

JSPRW 2.33%

JUNS 0.00%

JUNSW 0%

KA -5.56%

KALV -0.42%

KDNY 0.22%

KMPH -0.34%

KNSA -0.05%

KNTE -0.38%

KOD -0.37%

KPRX 8.51%

KPTI -0.28%

KRBP 4.17%

KRON 0.00%

KROS -1.60%

KRRO -0.63%

KRTX 0.03%

KRYS -0.42%

KTRA 10.17%

KTTA -2.85%

KTTAW 8.62%

KURA 1.02%

KYMR -0.38%

KYTX 2.13%

KZIA 8.44%

KZR 0.65%

LABP 0.57%

LBPH -0.98%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.19%

LENZ -1.30%

LEXX 2.73%

LEXXW -9.42%

LGND -0.46%

LGNDV 0.00%

LGVN -15.23%

LIAN 0.00%

LIFE 2.70%

LIPO -1.23%

LIXT 0.40%

LIXTW 27.74%

LJPC -0.32%

LMNL 0.12%

LOGC -0.72%

LPCN 4.72%

LPTX -0.25%

LQDA -0.23%

LRMR 0.72%

LSTA -4.97%

LTRN -2.24%

LUMO 0.00%

LVTX -1.42%

LXEO -1.05%

LXRX -0.29%

LYEL -0.45%

LYRA 0.55%

MACK 0.00%

MBIO 34.23%

MBRX -4.83%

MCRB -1.40%

MDGL 0.25%

MDNA -13.16%

MDWD 1.00%

MDXG -0.43%

MEIP 1.41%

MESO 2.07%

MGNX -2.80%

MGTA -7.74%

MGTX -1.14%

MGX 2.85%

MIRM 1.22%

MIRO 0.59%

MIST 2.96%

MITO 0.00%

MLEC -4.55%

MLECW 9.25%

MLND -5.36%

MLTX 0.09%

MLYS -0.66%

MNKD -0.11%

MNMD 1.59%

MNOV 0.00%

MNPR 3.39%

MOLN 2.88%

MOR -0.55%

MORF -0.50%

MREO 0.94%

MRKR -4.81%

MRNA -2.37%

MRNS 0.68%

MRSN -0.49%

MRTX -0.17%

MRUS -1.33%

MRVI -0.49%

MTCR -1.29%

MTEM 1.54%

MTP -18.50%

MURA -0.30%

MYMD -0.91%

NAMS 3.43%

NAMSW -7.61%

NAUT 1.17%

NBRV 0.71%

NBSE -1.56%

NBTX -6.05%

NCNA -0.17%

NERV 0.00%

NEXI -1.40%

NGM -1.28%

NGNE -3.95%

NKGN 0.78%

NKGNW 39.76%

NKTR -2.54%

NKTX -1.89%

NLSP 144.60%

NLSPW 6.21%

NMRA 1.29%

NMTR -42.97%

NOVN -24.84%

NRBO 0.45%

NRIX 4.55%

NRSN -4.95%

NRSNW 6.50%

NRXP 0.99%

NRXPW -15.65%

NRXS -6.06%

NTBL 2.92%

NTEC -12.45%

NTHI 0%

NTLA 0.00%

NTRBW -6.25%

NUVL -0.03%

NVAX -1.54%

NVCT 1.18%

NVIV -34.28%

NXTC 0.70%

NYMX -0.05%

OABI -2.11%

OABIW 13.46%

OBIO -0.87%

OBSV 0.00%

OCEA -2.98%

OCGN 2.90%

OCS -1.09%

OCUL -0.18%

OCUP 0.00%

ODT -4.27%

OKYO 0.00%

OLMA -1.18%

OMER -0.99%

OMGA 6.45%

ONCO 18.87%

ONCR -3.08%

ONCS 31.87%

ONCT -0.12%

ONCY -0.99%

ONTX -0.47%

ONVO -2.35%

OPNT 0.00%

OPT 0.80%

ORGS -1.72%

ORIC -0.13%

ORMP 0.00%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 1.54%

OVID -2.51%

OYST 0.00%

PALI 0.86%

PASG -0.99%

PBLA 9.76%

PBM -0.02%

PBYI -0.63%

PCSA 5.71%

PCVX -0.74%

PDSB -0.37%

PEPG 0.70%

PGEN 0.61%

PHAR 2.17%

PHAS 0.00%

PHAT -0.60%

PHIO 6.80%

PHIOW 36.47%

PHVS -0.53%

PHXM -5.20%

PIRS -5.64%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 0.27%

PLUR 0.57%

PMN 0.00%

PMVP 0.00%

PNT 0.16%

PPBT 2.78%

PRAX 5.58%

PRDS 0.93%

PRLD 0.77%

PROG -3.47%

PROK -0.34%

PRQR 1.18%

PRTA -0.51%

PRTC -0.72%

PRTG 6.52%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 0.00%

PSTX 1.81%

PTCT 0.06%

PTE -0.82%

PTGX 0.03%

PTIXW 2.50%

PULM 3.72%

PXMD -1.92%

PYPD -0.36%

PYXS 0.00%

QLGN 15.74%

QNCX -1.41%

QNRX 3.04%

QSI 0.75%

QSIAW 0.00%

QTTB 0.00%

QURE -0.43%

RAIN -1.63%

RANI 0.00%

RAPT -0.45%

RARE -1.56%

RCKT 0.19%

REGN 0.06%

RENB -1.26%

REPL -0.13%

RETA 0.02%

REUN -0.89%

REVB 5.31%

REVBU 3.46%

REVBW 25.20%

RGLS 0.42%

RGNX 1.33%

RIGL 2.01%

RLAY 0.99%

RLMD 0.00%

RLYB -0.34%

RNA -1.52%

RNAC -1.07%

RNAZ 0.00%

RNXT 0.45%

ROIV 0.09%

ROIVW 4.56%

RPHM -0.60%

RPRX 0.68%

RPTX 1.58%

RUBY 2.70%

RVLP -32.05%

RVMD -0.16%

RVMDW -23.93%

RVNC 0.00%

RVPH -0.68%

RVPHW 11.54%

RXDX 0.09%

RXRX -0.43%

RYTM 0.46%

RYZB 0.02%

RZLT 1.85%

SABS -2.75%

SABSW -32.14%

SAGE 0.98%

SANA -0.17%

SAVA -0.71%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -8.74%

SCPH 0.00%

SCPS 0.00%

SEEL -3.49%

SEER -0.58%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 1.55%

SGMT -0.47%

SGTX -2.56%

SIOX 22.63%

SLDB -0.40%

SLGL -2.22%

SLN -1.55%

SLNO 0.38%

SLRX 5.16%

SLS -3.17%

SMMT -0.64%

SNDX 0.13%

SNGX 0.79%

SNPX -3.97%

SONN -4.75%

SPPI -0.49%

SPRB 0.49%

SPRC -2.02%

SPRO 3.13%

SRNE 20.00%

SRPT 0.55%

SRRA 0.00%

SRRK -0.34%

SRZN -1.70%

STAB 0.00%

STOK -0.26%

STRO 0.94%

STSA 0.00%

STTK 0.51%

SURF -0.93%

SVRA -0.78%

SWTX -3.68%

SYBX -0.63%

SYRS -2.63%

TALS -0.73%

TARA -1.16%

TARS -0.45%

TBPH 0.83%

TCBP 1.78%

TCDA 0.00%

TCON 0.74%

TCRR 0.00%

TCRT -3.13%

TCRX -1.21%

TECH 0.07%

TENX -3.43%

TERN -1.00%

TFFP -2.05%

TGTX 0.39%

THRX 0.12%

TIL -2.06%

TLC 0.00%

TLSA 0.66%

TNGX -1.92%

TNXP 0.67%

TNYA 0.00%

TPST 0.52%

TRDA -3.61%

TRVI -0.18%

TRVN 1.90%

TSHA -13.01%

TSVT 0.25%

TTNP 1.45%

TVTX -0.27%

TYRA -0.39%

UBX 0.72%

UNCY -0.11%

URGN -8.37%

UTHR 0.08%

VACC 11.36%

VALN -2.51%

VAXX -0.11%

VBIV 1.15%

VBLT -8.77%

VCEL 0.50%

VCNX -1.54%

VCYT -0.09%

VERA -0.08%

VERU -0.18%

VERV -0.19%

VIGL -2.83%

VINC 1.05%

VIR -1.74%

VIRI -5.41%

VIRX -6.84%

VKTX 0.28%

VLON -13.04%

VNDA 0.38%

VOR 1.29%

VRCA 0.00%

VRDN -0.74%

VRNA 0.00%

VRPX -14.73%

VRTX 0.14%

VSTM -1.38%

VTGN 1.46%

VTVT -0.10%

VTYX -0.36%

VXRT 6.91%

VYGR 0.10%

VYNE 2.16%

VYNT 7.78%

WINT 5.19%

WVE 0.25%

XBIO 6.75%

XBIT -0.66%

XCUR -0.65%

XENE -0.18%

XERS 0.00%

XFOR -1.19%

XLO 2.96%

XLRN 0.00%

XNCR -0.41%

XOMA 0.00%

XOMAO -0.56%

XOMAP -0.14%

XRTX 2.88%

YMAB -0.38%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.67%

ZNTL -25.39%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-04	Bitetti Teresa Marie	Sell	34 000	Stock Option (Right to Buy)
2024-06-04	Gannon Steven	Sell	56 400	Common Stock
2024-06-04	Gannon Steven	Sell	141 011	Stock Option (Right to Buy)
2024-06-04	Gannon Steven	Sell	30 000	Stock Option (Right to Buy)
2024-06-04	Gannon Steven	Sell	17 000	Stock Option (Right to Buy)

INSIDER POWER
-67.27
Last 97 transactions
Buy: 3 027 300 \| Sell: 8 744 008

Koreliacija (AI algo v.1.1b): Overvalued: 0.06% $21.56 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.77 (moderate)

Trumpas: 0.84 (strong)

Signal:(74.81) Same movement expected

Fusion Pharmaceuticals Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
RGLS	0.952
DXPE	0.944
GHRS	0.93
CTHR	0.924
CDXC	0.924
IMPPP	0.921
GIFI	0.921
SWBI	0.921
QFIN	0.92
LFMDP	0.918

10 Labiausiai neigiamai susiję koreliacijos
RMGC	-0.948
IMRX	-0.947
ACAD	-0.945
PRTS	-0.941
MTEM	-0.94
CMTL	-0.94
CASI	-0.934
RGF	-0.934
AZ	-0.932
BTTX	-0.93

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Fusion Pharmaceuticals Koreliacija - Valiuta/Žaliavos

-0.59
( weak negative )

-0.80
( strong negative )

0.00
( neutral )

0.39
( neutral )

Fusion Pharmaceuticals Finansinės ataskaitos

Annual	2023
Pajamos:	$2.07M
Bruto pelnas:	$723 000 (34.96 %)
EPS:	$-1.450

FY	2023
Pajamos:	$2.07M
Bruto pelnas:	$723 000 (34.96 %)
EPS:	$-1.450

FY	2022
Pajamos:	$1.46M
Bruto pelnas:	$-57.43M (-3 931.14 %)
EPS:	$-2.00

FY	2021
Pajamos:	$1.44M
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-1.884

Financial Reports:

No articles found.

Fusion Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Fusion Pharmaceuticals

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company has a strategic collaboration agreement with AstraZeneca UK Limited to jointly discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.